Homovanillic Acid (HVA), Urine




Test Mnemonic

UHVA

CPT Codes

  • 83150 - QTY (1)

Aliases

  • HVA, Urine

Includes

  • Creatinine, Urine per volume
  • Creatinine, Urine per day
  • HVA per volume
  • HVA ratio to Creatinine
  • HVA per 24 hours

Performing Laboratory

ARUP


Specimen Requirements

Volume Type Container Collect Temperature Transport Temperature Special Instructions
4 mLUrine, 24-hour (well-mixed)Clean containerRefrigerate during collection.RefrigeratedAbstain from medications for 72 hours prior to collection.

Alternate Specimen Requirements

Volume Type Container Collect Temperature Transport Temperature Special Instructions
4 mLUrine, randomClean container RefrigeratedAbstain from medications for 72 hours prior to collection.

Minimum Specimen Requirements

Volume Type Container Collect Temperature Transport Temperature Special Instructions
1 mL     

Stability

Environmental Condition Description
AmbientUnacceptable
Refrigerated1 week
Frozen2 weeks

Days Performed

Sun, Tue - Sat

Turnaround Time

2 - 6 days

Methodology

Name Description
High Performance Liquid Chromatography/Tandem Mass Spectrometry (LC/MS/MS) 

Reference Range

HVA, Urine
Sex Age From Age To Type Range Range Unit
 18 Years99 YearsNormal0.0 - 15.0 mg/d
HVA, Urine mg/g CRT
Sex Age From Age To Type Range Range Unit
   Years2 YearsNormal0 - 42mg/g crt
 3 Years5 YearsNormal0 - 22mg/g crt
 6 Years17 YearsNormal0 - 15mg/g crt
 18 Years99 YearsNormal0 - 8mg/g crt

Special Info

Indicate total volume on requisition. Homovanillic Acid (HVA) results are expressed as a ratio to creatinine excretion (mg/g cr). HVA mass per day (mg/d) is not reported on specimens from patients younger than 18 years of age, for random specimens, urine collection periods other than 24 hours, or for urine volumes less than 400 mL/day. No reference interval is available for results reported in mg/L. This test is New York DOH approved.

Clinical Info

Medications which may interfere with catecholamines and their metabolites include amphetamines and amphetamine-like compounds, appetite suppressants, bromocriptine, buspirone, caffeine, chlorpromazine, clonidine, disulfiram, diuretics (in doses sufficient to deplete sodium), epinephrine, glucagon, guanethidine, histamine, hydrazine derivatives, imipramine, levodopa (L-dopa, Sinemet), lithium, MAO inhibitors, melatonin, methyldopa (Aldomet), morphine, nitroglycerin, nose drops, propafenone (Rythmol), radiographic agents, rauwolfia alkaloids (Reserpine), and vasodialators. The effects of some drugs on catecholamine metabolite results may not be predictable.